Cough virus helps combat liver cancer in adulthood

canceloutcancersymbol

A virus that cause respiratory illnesses and stomach upsets in children could help in the fight against primary liver cancer, according to a study. Reovirus stimulates the body’s own immune system to kill off the cancerous cells and is also able to kill off the hepatitis C virus – a common cause of primary liver cancer – at the same time, the researchers at the University of Leeds discovered.

These early stage findings are important because primary liver cancer is the third highest cause of cancer deaths worldwide and, if surgery is not an option, the prognosis is poor. Study co-leader Dr Stephen Griffin, Associate Professor of Viral Oncology at the University of Leeds, said: “Ultimately we hope that by simultaneously treating the tumor, and the hepatitis virus that is driving the growth of the tumor, we may provide a more effective therapy and improve the outcomes for patients.

“Current treatments for liver cancer that can’t be removed by surgery are mainly palliative with chemotherapy only tending to prolong life, rather than cure and it can have significant side effects.” The University of Leeds team found that Reovirus was successful in treating both liver cancer cells grown in the laboratory and those taken directly from patients undergoing surgery.

When introduced into the body, Reovirus stimulates an immune system factor known as interferon, which in turn causes the activation of a specific white blood cell called a Natural Killer cell. These Natural Killer cells then kill both the tumor, and cells infected with the hepatitis C virus.

Stimulating the immune system to kill cancer cells is known as immunotherapy. It differs from chemotherapy, in which the actual drugs kill the cancer cells. The researchers are now hoping to start the first in-human clinical trials. Study co-leader Professor Alan Melcher, now Professor of Translational Immunotherapy at the Institute of Cancer Research, London, said: “Our study establishes a completely new type of viral immunotherapy for the most common primary liver cancer type, hepatocellular carcinoma, which has a very poor prognosis in its advanced form.

17 Comments

  1. The very core of your writing whilst sounding agreeable at first, did not sit very well with me after some time. Somewhere within the sentences you actually managed to make me a believer but only for a while. I nevertheless have got a problem with your jumps in logic and one would do well to help fill in those gaps. In the event that you actually can accomplish that, I could definitely end up being fascinated.

  2. Howdy very cool web site!! Guy .. Excellent .. Superb .. I’ll bookmark your web site and take the feeds additionally…I’m happy to seek out numerous useful information here within the put up, we need work out extra techniques in this regard, thank you for sharing. . . . . .

  3. Good – I should certainly pronounce, impressed with your web site. I had no trouble navigating through all tabs as well as related info ended up being truly easy to do to access. I recently found what I hoped for before you know it in the least. Quite unusual. Is likely to appreciate it for those who add forums or something, web site theme . a tones way for your client to communicate. Excellent task..

  4. certainly like your website but you have to check the spelling on several of your posts. A number of them are rife with spelling problems and I in finding it very troublesome to tell the reality however I?¦ll surely come again again.

  5. I am not positive where you are getting your info, but great topic. I must spend a while learning much more or understanding more. Thank you for magnificent info I used to be looking for this info for my mission.

  6. Oh my goodness! an incredible article dude. Thank you Nonetheless I’m experiencing situation with ur rss . Don’t know why Unable to subscribe to it. Is there anybody getting equivalent rss drawback? Anyone who is aware of kindly respond. Thnkx

  7. Magnificent goods from you, man. I’ve understand your stuff previous to and you’re just too wonderful. I really like what you’ve acquired here, certainly like what you are saying and the way in which you say it. You make it entertaining and you still take care of to keep it sensible. I can’t wait to read far more from you. This is actually a tremendous web site.

Leave a Reply

Your email address will not be published.